Methofill
Methotrexate is indicated for the treatment of
− active rheumatoid arthritis in adult patients,
− polyarthritic forms of severe, active juvenile idiopathic arthritis, when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate,
− severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, PUVA, and retinoids, and severe psoriatic arthritis in adult patients.
− mild to moderate Crohn’s disease either alone or in combination with corticosteroids in adult patients refractory or intolerant to thiopurines.
Link to Abbreviated Prescribing Info available below.
Referral Forms
API Documents
Patient Information Leaflets (PILs)
You can report side effects directly via the HPRA website www.hpra.ie, by emailing the HPRA Pharmacovigilance department at [email protected], or by calling the HPRA on 01-676 4971.
Please also report side effects to Accord Healthcare Ireland Ltd, by calling 0044 (0) 1271 385257. By reporting side effects you can help provide more information on the safety of this medicine.
Information placed on this digital platform is not intended as a substitute for consultation with your healthcare professional. Please read carefully the instructions on the package leaflet and consult your healthcare professional for any further information you may require.
Reporting of side effects: If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the HPRA website www.hpra.ie, by emailing the HPRA Pharmacovigilance department at [email protected], or by calling the HPRA on 01-676 4971.
Please also report side effects to Accord Healthcare Ireland Ltd, by calling 0044 (0) 1271 385257.
By reporting side effects you can help provide more information on the safety of this medicine.
